Endologix L L C

FDA Filings

This page includes the latest FDA filings for Endologix L L C. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
GUDID 00850032145077 Endologix LLC	TORUS Stent Graft System TSG-6.7X200	2026-02-04
GUDID 00850032145060 Endologix LLC	TORUS Stent Graft System TSG-6.7X150	2026-02-04
GUDID 00850032145053 Endologix LLC	TORUS Stent Graft System TSG-6.7X100	2026-02-04
GUDID 00850032145046 Endologix LLC	TORUS Stent Graft System TSG-6.0X200	2026-02-04
GUDID 00850032145039 Endologix LLC	TORUS Stent Graft System TSG-6.0X150	2026-02-04
GUDID 00850032145022 Endologix LLC	TORUS Stent Graft System TSG-6.0X100	2026-02-04
GUDID 00850032145015 Endologix LLC	TORUS Stent Graft System TSG-5.5X200	2026-02-04
GUDID 00850032145008 Endologix LLC	ENDOCROSS Device ENDOCROSS	2025-10-02
PMA P040002S068 Endologix, LLC	AFX2 Endovascular AAA System	2021-06-17
PMA P040002S067 Endologix, LLC	AFX Endovascular AAA System (AFX System)	2021-04-08
PMA P120006S037 Endologix, LLC	Alto Abdominal Stent Graft System	2020-10-09

Similar & Related FDA Registered Companies

• Endologix, LLC3910 Brickway Blvdsanta Rosa, CA 95403 PMA NumberP120006 Supplement NumberS041 Date Received12/02/2022 Decision Date12/22/2022 Product Code MIH  Advisory Committee Cardiovascular Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No
• Endologix, LLC2 Musickirvine, CA 92618 PMA NumberP040002 Supplement NumberS070 Date Received03/15/2022 Decision Date12/06/2022 Product Code MIH  Advisory Committee Cardiovascular Supplement Typenormal 180 Day Track Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No